18

DAFTAR PUSTAKA
(1) T. N. Taylor, P. H. Davis, J. C. Torner, J. Holmes, J. W. Meyer, and M. F. Jacobson, Lifetime cost of stroke in the United States, Stroke Research and Treatment, vol. 27, no. 9, pp. 14591466, 1996. (2) http://www.who.int/topics/cerebrovascular_accident/en/ (3) Kusuma Y, Venketasubramanian N, Kiemas LS, Misbach J. Burden of stroke in Indonesia. PubMed U.S. National Library of Medicine National Institutes of Health. 2009; 4(5) : 379-380 (4) Jusuf Misbach and Wendra Ali. Stroke in Indonesia: A first large prospective hospital-based study of acute stroke in 28 hospitals in Indonesia. Journal of Clinical Neuroscience. 2001. Volume 8, Issue 3 Pages 245-249 (5) S. E. Straus, S. R. Majumdar, and F. A. McAlister, New evidence for stroke prevention: scientific review, Journal of the Stroke Research and Treatment 5 AmericanMedical Association, vol. 288, no. 11, pp. 13881395, 2002. (6) J. A. Ezekowitz, S. E. Straus, S. R.Majumdar, and F. A.McAlister, Stroke: strategies for primary prevention, American Family Physician, vol. 68, no. 12, pp. 23792389, 2003. (7) R. Collins, R. Peto, S. MacMahon et al., Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context, Lancet, vol. 335, no. 8693, pp. 827 838, 1990. (8) CarmineMarini, Tommasina Russo, and Giorgio Felzani. Incidence of Stroke in Young Adults: A Review. Journal of Stroke Research and Treatment. 2010. Volume 2011 Page : 1 2. (9) S. J. Kittner, R. J. McCarter, R.W. Sherwin et al., Black-white differences in stroke risk among young adults, Stroke, vol. 24, supplement 1, pp. I13I15, 1993. (10) Khackik, F. et al. (1999) Lutein, lycopene and their oxidative metabolites in chemoprevention of cancer. Journal of Cellular Biochemistry, Supplement 22:236246. (11) DiMascio, P. et al. (1998) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Archives Biochimica et Biophysica 274:532-538. (12) Bendich, A. and Olson, J.A. (1999) Biological action of carotenoids. FASEB Journal 3:1927-1932 (13) American Stroke Association. www.strokeassociation.org. Accessed April 29, 2009. National Institutes of Health. www.nlm.nih.gov. Accessed April 29, 2009. National Institute of Neurological Disorders and Stroke. www.ninds.nih.gov. Accessed April 29, 2009. National Stroke Association. (14) Aliah A, Muis Abd (2000) : Strok dan Hipertensi; Simposium Strok : Hotel Sedona di Makassar 2000. (15)European Stroke Initiative, recommendation 2003. EUSI, Ischemic Stroke. Prophylaxis and treatment, Information for Doctors in hospitals and practice. 2003 (16) Bogousslavsky, J. Meeting the challenge of stroke : on the attack. Oddyssey, 3/3 : 1996. (17) WHO. 1999, World Health Report 1999. Geneva : WHO. (18) Sylvia A. Price, Lorraine M. Wilson. Patofisiologi Konsep Klinis Proses Penyakit. 2006. Jakarta : EGC.

19

(19) Meier-Ruge, W : The Pathophisiology of Stroke, causes and mechanism of cerebral infarction in Meier Ruge W. (ed) Vascular Brain Disease in All Age, Teaching and Training in Geriatric Medicine. Karger AG Switzerland ; 1990. p 43 85. (20) Van Gijin, J. Subarachnoid Hemorrhage in stroke Octet, Lancet, 1992 ; 339/8794, 653-656. (21) Sudoyo, Aru W. et all. Ilmu Penyakit Dalam Edisi I Jilid V. 2009. Jakarta : Interna Publishing. (22) Suhanda, Irwan. Buku Sehat dengan Makanan Berkhasiat. 2004. Bandung : PT. Gramedia Pustaka. (23) Bendich, Adrianne. "From 1989 to 2001: What Have We Learned about the 'Biological Actions of Beta-carotene?'" Journal of Nutrition 134, no. 1 (January 2004): 125S130S. (24) Clark, Jim. Spektra Serapan UV-Tampak. 2007. Jakarta (25) Jaana M. Leppa la , MD; Jarmo Virtamo, MD; Rainer Fogelholm, MD; Demetrius Albanes, MD; Philip R. Taylor, MD, DSc; Olli P. Heinonen, MD, DSc. Vitamin E and Beta Carotene Supplementation in High Risk for Stroke. 2000